HCV Coinfection Completed Phase 4 Trials for Ombitasvir (DB09296)

Also known as: Hepatitis (non-A non-B) / Viral hepatitis C / Hepatitis non-A non-B / Non-A non-B hepatitis / Hepatitis C / Unspecified viral hepatitis C / Hep non-A non-B

IndicationStatusPhase
DBCOND0048683 (HCV Coinfection)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03499639Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney DiseaseTreatment
NCT03050905Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1BTreatment